Eli Lilly Begins Testing Covid-19 Drug Derived From Blood of Survivor

Lilly began the first study of an experimental drug derived from a blood sample of an early U.S. survivor of Covid-19, a new effort to take advantage of the molecular defenses developed by recovered patients.